A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung
Sponsors and Collaborators
Sarcoma Alliance for Research through Collaboration
Ann Johnson, RN, CCRC
Kristin Baird, MD
National Cancer Institute-Pediatric Oncology Branch
Next post in Bone Cancer Clinical Trials
Want to view more content from Cancer Therapy Advisor?
Register now at no charge to access unlimited clinical news, full-length features, case studies, conference coverage, and more.
Want to read more?
Please login or register first to view this content.